MindBio Therapeutics Corp.
MBIO
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -415.60K | -130.70K | -2.00K |
| Total Revenue | -- | -- | -415.60K | -130.70K | -2.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -415.60K | -130.70K | -2.00K |
| SG&A Expenses | 1.94M | 1.20M | 265.30K | 340.90K | 344.70K |
| Depreciation & Amortization | 1.20K | 1.00K | -600.00 | 25.90K | -400.00 |
| Other Operating Expenses | 17.10K | 17.80K | 17.80K | 17.80K | 17.80K |
| Total Operating Expenses | 1.96M | 1.22M | 282.50K | 384.50K | 362.00K |
| Operating Income | -1.96M | -1.22M | -698.10K | -515.20K | -364.00K |
| Income Before Tax | -2.55M | -1.79M | -1.04M | -401.10K | -177.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.55 | -1.79 | -1.04 | -0.40 | -0.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00 | -100.00 | 3.20K | 2.40K | -400.00 |
| Net Income | -2.55M | -1.79M | -1.04M | -398.70K | -177.60K |
| EBIT | -1.96M | -1.22M | -698.10K | -515.20K | -364.00K |
| EBITDA | -1.93M | -1.14M | -168.40K | 40.90K | 194.70K |
| EPS Basic | -3.37 | -3.37 | -3.36 | -1.45 | -0.82 |
| Normalized Basic EPS | -1.38 | -1.38 | -1.18 | -0.90 | -0.51 |
| EPS Diluted | -3.37 | -3.37 | -3.36 | -1.45 | -0.82 |
| Normalized Diluted EPS | -1.38 | -1.38 | -1.18 | -0.90 | -0.51 |
| Average Basic Shares Outstanding | 345.07M | 111.85M | 111.01M | 111.00M | 110.91M |
| Average Diluted Shares Outstanding | 345.07M | 111.85M | 111.01M | 111.00M | 110.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |